XATRAL
XATRAL
Approved
DIN Number
02245565
Drug Class
Human
Market Date
Feb 21, 2002
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245565
AIG Number0146806001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04CA01 ALFUZOSIN
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification12:16.04.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALFUZOSIN HYDROCHLORIDEActive
Strength: 10 MG
Monograph: ALFUZOSIN HYDROCHLORIDE